1. Comparison of early outcomes of primary total knee arthroplasties performed using subvastus and medial parapatellar approaches and evaluation of quadriceps muscle elastography.
- Author
-
Güven MF, Özer M, Özşahin MK, Değer GU, Adaletli İ, Aykan Kargin O, Kaynak G, and Botanlıoğlu H
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Patella surgery, Patella diagnostic imaging, Treatment Outcome, Arthroplasty, Replacement, Knee methods, Elasticity Imaging Techniques methods, Quadriceps Muscle diagnostic imaging
- Abstract
Background: In primary total knee arthroplasty (TKA) surgeries, the medial parapatellar (MP) and subvastus (SV) approaches are frequently employed. The SV approach involves preserving the vastus medialis muscle, leading to debates about the possibility of earlier healing of the extensor mechanism. Shear wave elastography (SWE) is known for monitoring tissue healing. In this study, our research question revolves around whether there exist differences in tissue healing following MP and SV approaches. Unlike previous studies, we aim to investigate this difference using solely SWE, which provides a quantitative measurement specifically targeting the vastus medialis muscle., Methods: We divided 17 patients into two groups: SV (10 patients) and MP (7 patients). SWE measurements and clinical scores were recorded before surgery and at the 3rd-month follow-up. The first straight leg raising days were also recorded., Results: Both the MP and SV groups showed significant improvement in clinical scores postoperatively. Straight leg raising time was comparatively earlier in the SV group, but no significant difference was found. SWE measurements revealed similar recovery values in the vastus medialis muscle between the two groups., Conclusion: Both MP and SV approaches demonstrate similar and favorable early outcomes in TKA surgery. The preservation of the vastus medialis in the SV approach does not lead to significant differences in clinical scores or muscle recovery compared to the MP approach., Trial Registration: The study was retrospectively registered on ClinicalTrials.gov on March 7, 2024 (NCT06297746). https://classic., Clinicaltrials: gov/ct2/show/NCT06297746?id=am7mi3VB&draw=2&rank=1 ., Competing Interests: Declarations. Ethical approval: This study was performed following the principles of the Declaration of Helsinki. The study protocol was approved by the Istanbul University - Cerrahpaşa, Clinical Research Ethics Committee (Application code: am7mi3VB). Informed consent: Informed consent was obtained from all individual participants included in the study. Permission to publish was obtained from all participants. Conflict of interest: All authors declare that they have no conflict of interest., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF